• Profile
Close

Use of proton pump inhibitors increases risk of incident kidney stones

Clinical Gastroenterology and Hepatology Aug 08, 2020

Simonov M, Abel EA, Skanderson M, et al. - Whether and how proton pump inhibitor (PPI) use is related to kidney stones was examined in this retrospective analysis utilizing data from the Women’s Veteran’s Cohort Study. Data regarding PPI usage over time, demographics, laboratory findings, comorbidities, and medication usage were obtained from 465,891 patients. Use of histamine-2 receptor antagonists (H2RAs) was determined and levothyroxine use was a negative control exposure. Greater risk of kidney stones was observed in relation to increased dosage of PPI. Increased risk was also noted in correlation with H2RAs. In adjusted analysis, there was no link of levothyroxine use with kidney stones. Overall, PPI use was identified to be related to a dose-dependent rise in kidney stone risk in a large cohort study of veterans. Acid suppression may be an involved mechanism, due to the link between H2RA use and kidney stone risk. Prescribing for most patients will not need to be changes since the effect is small.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay